Cas:2179-92-2 tri-n-butylcyanotin manufacturer & supplier

We serve Chemical Name:tri-n-butylcyanotin CAS:2179-92-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tri-n-butylcyanotin

Chemical Name:tri-n-butylcyanotin
CAS.NO:2179-92-2
Synonyms:Tributylcyanotin;Tributyltin cyanide;Tin,tributylcyano;Tributylstannanecarbonitrile;EINECS 247-295-4;tris(n-butyl)tin cyanide;Tri-n-butyltin cyanide;tributylstannyl cyanide;Stannanecarbonitrile,tributyl;MFCD00009698
Molecular Formula:C13H27NSn
Molecular Weight:316.06100
HS Code:2931900090

Physical and Chemical Properties:
Melting point:105-107ºC(lit.)
Boiling point:300.1ºC at 760mmHg
Density:N/A
Index of Refraction:
PSA:23.79000
Exact Mass:317.11700
LogP:4.89828

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3146 6.1/PG 2
Packing Group:II


Contact us for information like Tributylcyanotin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00009698 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Tributylstannanecarbonitrile Use and application,Stannanecarbonitrile,tributyl technical grade,usp/ep/jp grade.


Related News: Alira’s work spans the gamut from transaction advisory to regulatory services to advanced analytics, management consulting, product development and clinical investigator training, to name a few. With the CROS NT deal, Alira secures not only a biometrics presence but also a portfolio of electronic data capture systems. tri-n-butylcyanotin manufacturer Of the nearly 4,000 Black women and more than 25,000 white women included in the study, there was no statistically significant difference in breast cancer-related genetic mutations. They were found in 5.65% of Black women and nearly 5.1% of white women. tri-n-butylcyanotin supplier A 40-year-old Chinese woman also tested positive. She was already in quarantine as she is related to another patient who contracted the virus. tri-n-butylcyanotin vendor High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies. tri-n-butylcyanotin factory Alira’s work spans the gamut from transaction advisory to regulatory services to advanced analytics, management consulting, product development and clinical investigator training, to name a few. With the CROS NT deal, Alira secures not only a biometrics presence but also a portfolio of electronic data capture systems.